<DOC>
	<DOCNO>NCT00268411</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , gemcitabine oxaliplatin , work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill tumor cell . It yet know whether give drug day effective give different day . PURPOSE : This randomized phase III trial study two different schedule gemcitabine oxaliplatin compare well work treat patient metastatic pancreatic cancer .</brief_summary>
	<brief_title>Gemcitabine Oxaliplatin Treating Patients With Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare objective response rate patient metastatic adenocarcinoma pancreas treat two different schedule gemcitabine hydrochloride oxaliplatin . Secondary - Compare clinical benefit tolerability regimens patient . - Compare progression-free overall survival patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center ECOG performance status ( 0 1 v 2 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive gemcitabine hydrochloride IV 100 minute day 1 oxaliplatin IV 2 hour day 2 . - Arm II : Patients receive gemcitabine hydrochloride IV 100 minute follow oxaliplatin IV 2 hour day 1 . In arm , treatment repeat every 14 day absence disease progression unacceptable toxicity . After completion study treatment , patient follow periodically . PROJECTED ACCRUAL : A total 80 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma pancreas Metastatic disease Measurable disease ( primary tumor metastasis ) At least 1 cm diameter spiral CT scan No ampulla Vater carcinoma biliary adenocarcinoma No known brain metastasis PATIENT CHARACTERISTICS : ECOG performance status ( PS ) 02 Karnofsky PS 60100 % Life expectancy 12 week Absolute neutrophil count &gt; 1,500/mm^3 Platelet count &gt; 100,000/mm^3 Alkaline phosphatase &lt; 5 time normal Bilirubin &lt; 1.5 time normal Creatinine &lt; 1.5 time normal No preexisting neuropathy No unstable uncontrolled pain Not pregnant nursing Fertile patient must use effective contraception No serious cardiovascular disease No serious respiratory disease No uncontrolled persistent hypercalcemia No psychological , familial , social , geographical condition would preclude study treatment No active malignancy PRIOR CONCURRENT THERAPY : No prior chemotherapy radiotherapy No concurrent corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>